Peakdale Receives French Research Tax Credit (CIR) AccreditationBy Peakdale Molecular Ltd, PRNE
Tuesday, January 11, 2011
CHAPEL-EN-LE-FRITH, England, January 12, 2011 - Peakdale Molecular, a leading discovery and research services
company, announced today that it has received the CIR accreditation from the
French Ministry of Higher Education and Research.
This accreditation recognises Peakdale as an approved provider
of research services to companies in France, thereby allowing French
pharmaceutical, biotech and technology companies to benefit from significant
tax relief on research carried out by Peakdale on their behalf.
Dr. Mick Durrant, Peakdale's Director of Business Development,
commented: "We are thrilled to receive this approval from the French Ministry
of Higher Education and Research, which will support the development of the
Peakdale client base in France. Our French customers will be able to recoup
significant R&D costs through this innovative scheme."
For further information concerning the Credit d'Impot sur la
Recherche, please visit www.enseignementsup-recherche.gouv.fr
About Peakdale Molecular Limited
Peakdale Molecular is based in Chapel-en-le Frith, Derbyshire
and has been established as a provider of research services to the
pharmaceutical and biotechnology industry since 1992. In state of the art
laboratories with over 90 chemists it continues to provide problem solving
expertise from discovery to scale up across Europe and the USA. For more
information on Peakdale Molecular, please visit www.peakdale.co.uk.
CONTACT Dr. Mick Durrant Director of Business Development Telephone: +44-1298-816-700 firstname.lastname@example.org
CONTACT: Dr. Mick Durrant, Director of Business Development, Telephone: +44-1298-816-700, mick.durrant at peakdale.co.uk
Tags: Chapel-en-le-frith, England, France, January 12, Peakdale Molecular Ltd, United Kingdom